24 Psoriatic arthritis (PsA) is a debilitating immune-mediated inflammatory arthritis of unknown pathogenesis 25 commonly affecting patients with skin psoriasis. We used three complementary single cell approaches to 26 study leukocytes from PsA joints. Mass cytometry (CyTOF) demonstrated marked (>3 fold) expansion of 27 memory CD8 T cells in the joints compared to matched blood. Further exploration of the memory CD8 28 compartment using both droplet and plate based single cell RNA sequencing of paired alpha and beta chain 29 T cell receptor sequences identified pronounced CD8 T cell clonal expansions within the joints, strongly 30 suggesting antigen driven expansion. These clonotypes exhibited distinct gene expression profiles including 31 cycling, activation, tissue homing and tissue residency markers. Pseudotime analysis of these clonal CD8 32 populations identified trajectories in which tissue residency can represent an intermediate developmental 33 state giving rise to activated, cycling and exhausted CD8 populations. Comparing T-cell clonality across 34 patients further revealed specificity convergence of clones against a putative common antigen. We identify 35 chemokine receptor CXCR3 as upregulated in expanded synovial clones, and elevation of two CXCR3 ligands, 36 CXCL9 and CXCL10, in PsA synovial fluid. 37 38 39 Up to one third of patients suffering from psoriasis develop the debilitating immune-mediated inflammatory 40 joint disease, psoriatic arthritis (PsA) 1 . The pathogenesis of PsA is complex, involving multiple inflammatory 41 pathways 2 . Genome-wide association studies of both psoriasis and PsA support a pathogenic role for CD8 T cells,
42
showing significant associations with MHC class I and other T cell genes 3 . A subgroup of patients with PsA 43 develop a distinct pattern of arthritis, termed large-joint oligo PsA, which affects large joints including the 44 knees 4 . These patients often require therapeutic aspiration which provides an opportunity to examine the 45 synovial exudate in PsA. Here, we study the cellular landscape of PsA blood and synovial fluid at single cell 46 resolution (Figure 1A) , combining mass cytometry with droplet-encapsulated single cell mRNA sequencing 47 (Chromium 10x) and validation by full length transcript (Smart-seq 2) single cell mRNA sequencing (Figure 1B) .
48
We first used mass cytometry (CyTOF) to quantify leucocyte populations from matched synovial fluid and blood 49 obtained from 10 patients presenting with large-joint oligo psoriatic arthritis for arthrocentesis ( Figure 1C-D) .
50
Blood and synovial samples were fixed within 30 minutes of collection, stained with a 38-marker panel 51
( Supplementary Table 1 ) and then acquired on a CyTOF Helios instrument. After pre-processing, we used t-52 3 stochastic neighbour embedding (tSNE) to derive cell clusters (Figure 1C) , which were annotated by FlowSOM 5 53 (Supplementary Figure 1) . These analyses identified significant expansions in all patients of synovial memory 54 CD8 (p=0.0059, paired t-test) and CD4 (p=0.025, paired t-test) T cells (Figure 1D-E) compared to blood. Other 55 populations expanded in synovial fluid were plasmacytoid (p = 0.032, paired t-test) and conventional dendritic 56 cells (p = 0.013, paired t-test) indicating increased capacity for antigen presentation. B cells and basophils were 57 depleted (p = 0.0059 for both, paired t-test), and monocytes, gamma-delta T, mucosal invariant T (MAIT) 6 and 58 NK cells were unchanged (Figure 1D) . 3' droplet-encapsulated single cell mRNA sequencing of PBMC and SFMC 59 from three PsA patients, carried out in parallel, confirmed the presence of these cell types and did not identify 60 any additional cellular populations (Supplementary Figure 1) . 68 2). After applying stringent quality control criteria (Methods), we studied 39,252 single cell transcriptomes of 69 equal patient and tissue origin using 10x ( Supplementary table 1) , which were integrated using the Seurat 3 70 pipeline to derive cell clusters (Supplementary Figure 2) . We found 16 clusters of memory CD4 and CD8 T cells 71 in synovial fluid and blood (Figure 1F ), annotated with key marker genes in Figure 1G ( Supplementary Table 1 ,
72
Supplementary Figure 2 ). Of note one cluster (cluster 15) derived from all three patients and predominantly 73 composed of synovial CD8 T cells, was distinguished by high expression of the proliferation marker MKI67,
74
indicating active proliferation of CD8 T cells within inflamed joints.
75
We next looked for evidence of clonal expansion of CD4 and CD8 T cells in the blood and synovial fluid of each 76 of the three donors using the 10x data set (Figure 2A 
89
To validate these specificity groups we studied a further 1441 synovial CD4 and CD8 T cells with 1236 unique 90 beta chain CDR3 amino acid sequences from three independent patients in the Smart-seq 2 data set. GLIPH 91 analysis incorporating these sequences with the original 10x TCR sequences obtained from 40915 cells identified 92 5 TCR specificity groups common to all 6 patients. One of these 5 groups (CRG-1) was again assigned the "NQNT" (Figure 3F) . Both CXCR3 ligands 135 were highly enriched in the synovial fluid compared to blood (p = 0.0004 for CXCL10, p = 0.007 for CXCL9, paired 6 t-test). CXCR3 is known to be expressed on activated Th1 and CD8 T cells and plays a key role in chemotaxis 137 during inflammation 14, 15 . Interestingly, CXCR3-expressing T cells have previously been shown to be depleted in 138 peripheral blood of patients with psoriasis, which had been speculated to be due to recruitment of these cells 139 into skin lesions 16 . Our findings raise the possibility that CXCR3+ CD8 T cells play a central role in executing 140 localised inflammation in PsA and thus represent an attractive therapeutic target. Further analysis revealed that 141 cells belonging to CRG-1 and cells from related clusters 4, 10 and 15 had selectively higher CX3CR1 gene 142 expression in blood ( Supplementary Figure 4) , potentially providing additional means to identify and target 143 convergence group related CD8 T cells in blood.
144
In this study we have defined and characterized clonal expansions of CD8 T cells in the joints of patients with After cell containing droplets were identified, gene expression matrices were first filtered to remove cells 206 with > 10% mitochondrial genes, < 500 or > 3500 genes, and > 25000 UMI. Cells were further filtered to 207 include only cells with corresponding CDR3 TCR data and to exclude potential multiplets, defined as cells 208 with greater than 1 beta chain or 2 alpha chains or cells having both CD4 and CD8 gene expression (given 209 the sorting strategy used).
211
Quality control of SS2 based single cell expression data 212 Cells with more than 5 median absolute deviations (MAD) 8.35% of their mRNA originating from 213 mitochondrial genes; a total number of reads <500,000 or > 5000000; a total number of counts >3 median 214 absolute deviations (MAD); or with number of genes <1000 or > 6000, were filtered out prior to downstream 215 analysis. Where matching TCR data for a cell was available, any cells with greater than 1 beta chain or 2 216 alpha chains were additionally filtered. 
